HIGHLAND, MD – The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG) today announced funding to Daniele Gilkes, Ph.D., at Johns Hopkins’ University, for research that aims to better understand breast cancer metastasis and builds on a previous JKTG-funded pilot project at the Gilkes’ lab.
“Daniele’s work suggests that organs play a unique role in development of metastasis and understanding how cells survive and spread,” said Ted Giovanis, founder and president of the JKTG Foundation. “Most research in this area approaches metastasis through the lens of how cancer cells use and need oxygen. Daniele’s approach takes that to another level. We’re excited to build on initial findings by funding this next phase.”
JKTG funded initial research in which the modeling work of Gilkes and her collaborator Paul Macklin, Ph.D., resulted in the unexpected finding that cells experiencing hypoxia, or oxygen deprivation, in the primary tumor prefer to metastasize to the brain and liver instead of in the lung and lymph nodes. The new research will investigate how and why that occurs in order to define biomarkers and therapeutic targets tailored to the site of the metastatic spread giving new hope for viable treatment strategies to patients living with metastatic breast cancer.
ABOUT THE JKTG FOUNDATION
The Jayne Koskinas Ted Giovanis Foundation for Health and Policy (JKTG Foundation) aims to change health care for the better. Funding innovative medical research, data analysis, events, and other projects, the Foundation serves as an honest, independent broker of ideas and actions designed to advance both health care and health policy. Visit www.jktgfoundation.org to learn more.
MEDIA CONTACT: Amy Lee / 202.280.8816 / [email protected]
Featured news
Ted’s Take: It’s about the money
Money is what seems to drive things and money is what seems to drive organizations too. They all start with an overriding moral goal but after a while things often turn toward more money.
Ted’s Take: The best patient advocate? You.
When you’re a patient, you are kind of vulnerable. You have a problem, are often sketchy about what it is and the potential treatment or therapy needed. The bigger the problem, the more vulnerable you are. This makes you a perfect advocate.
Targeting effective treatments for triple-negative breast cancer
The JKTG Foundation recently awarded funding to Laura Heiser, Ph.D., Associate Professor and Vice Chair of Biomedical Engineering at the Oregon Health & Science University (OHSU) School of Medicine, to develop a prototype multiscale model designed to predict therapeutic responses of tumor ecosystems – a new frontier in breast cancer research.
Jayne Koskinas Ted Giovanis
Foundation for Health and Policy
PO Box 130
Highland, Maryland 20777
Media contact: 202.548.0133